世界のスニチニブリンゴ酸塩市場2021年ー2027年:種類別(純度99%以上、純度98%以上、純度97%以上)、用途別、地域別

◆英語タイトル:Global Sunitinib malate market Size study, by Type (Purity: >99%, Purity: >98%, Purity: >97%), by Application (Pancreatic Neuroendocrine Tumors, Kidney Cancer, Gastrointestinal stromal tumor) and Regional Forecasts 2021-2027
◆商品コード:BZW21UJ034
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2021年6月11日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥712,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Bizwit Research社の本調査資料では、世界のスニチニブリンゴ酸塩市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別(純度99%以上、純度98%以上、純度97%以上)分析、用途別(膵臓神経内分泌腫瘍、腎臓がん、消化管間質腫瘍)分析、地域別分析、競争状況、調査プロセスなど、以下の項目を掲載しています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界のスニチニブリンゴ酸塩市場規模:種類別(純度99%以上、純度98%以上、純度97%以上)
・世界のスニチニブリンゴ酸塩市場規模:用途別(膵臓神経内分泌腫瘍、腎臓がん、消化管間質腫瘍)
・世界のスニチニブリンゴ酸塩市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Sunitinib malate market is valued at approximately XX in 2020 and is anticipated to grow with a healthy growth rate of more than XX over the forecast period 2021-2027. Sunitinib malate is a small-molecule medication that has been shown to block several tyrosine kinases in different receptors (RTKs). Sunitinib is recognized as an effective drug in suppressing cell proliferation and angiogenesis due to its potential antineoplastic action. Sunitinib capsules are used to treat pancreatic neuroendocrine tumors, renal cancer, and gastrointestinal stromal tumors (GIST). Sunitinib was the first cancer treatment to be licensed for two indications at the same time: renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor (GIST). The global sunitinib malate market is primarily driven by technological advancements and the rising prevalence of pancreatic cancer. Pancreatic cancer’s rising prevalence is a primary driver of the worldwide sunitinib capsules market. According to the American Cancer Society, over 56,000 Americans will be diagnosed with pancreatic cancer in 2017, with over 42,000 of them anticipated to die by pancreatic cancer. Pancreatic tumors are more difficult to diagnose and remove than other tumors due to their relative inaccessibility. As a result, sunitinib malate capsules are increasingly being used to treat pancreatic cancers. However, higher cost of research and development(R&D), and high cost of sutent may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Sunitinib malate market is considered for the key regions such as North America Asia Pacific, , Latin America, Europe, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to rising prevalence of pancreatic cancer in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to growing awareness about pancreatic cancer in developing economies such as India, China, and others.

Major market player included in this report are:
Pfizer Incorporation
Topcarepharm
Njfirstpharm
J&K Scientific
Targetmol
Synthland Ltd
Teva Pharmaceutical Industries Ltd.
Astellas Pharma, Inc.
Dendreon Corporation
Ferring Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Purity: >99%
Purity: >98%
Purity: >97%

By Application:
Pancreatic Neuroendocrine Tumors
Kidney Cancer
Gastrointestinal stromal tumor

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.

Target Audience of the Global Sunitinib malate market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Sunitinib malate market , by Region, 2019-2027 (USD Billion)
1.2.2. Sunitinib malate market , by Type, 2019-2027 (USD Billion)
1.2.3. Sunitinib malate market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Sunitinib malate market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Sunitinib malate market Dynamics
3.1. Sunitinib malate market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of pancreatic cancer
3.1.1.2. Increasing prevalence of pancreatic neuroendocrine tumours
3.1.2. Market Restraint
3.1.2.1. High cost of Sutent
3.1.3. Market Opportunities
3.1.3.1. Increase in Pharmaceutical R&D Spending
Chapter 4. Global Sunitinib malate market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Sunitinib malate market , by Type
5.1. Market Snapshot
5.2. Global Sunitinib malate market by Type , Performance – Potential Analysis
5.3. Global Sunitinib malate market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Sunitinib malate market , Sub Segment Analysis
5.4.1. Purity: >99%
5.4.2. Purity: >98%
5.4.3. Purity: >97%
Chapter 6. Global Sunitinib malate market , by Application
6.1. Market Snapshot
6.2. Global Sunitinib malate market by Application, Performance – Potential Analysis
6.3. Global Sunitinib malate market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Sunitinib malate market , Sub Segment Analysis
6.4.1. Pancreatic Neuroendocrine Tumors
6.4.2. Kidney Cancer
6.4.3. Gastrointestinal stromal tumor
Chapter 7. Global Sunitinib malate market , Regional Analysis
7.1. Sunitinib malate market , Regional Market Snapshot
7.2. North America Sunitinib malate market
7.2.1. U.S. Sunitinib malate market
7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Sunitinib malate market
7.3. Europe Sunitinib malate market Snapshot
7.3.1. U.K. Sunitinib malate market
7.3.2. Germany Sunitinib malate market
7.3.3. France Sunitinib malate market
7.3.4. Spain Sunitinib malate market
7.3.5. Italy Sunitinib malate market
7.3.6. Rest of Europe Sunitinib malate market
7.4. Asia-Pacific Sunitinib malate market Snapshot
7.4.1. China Sunitinib malate market
7.4.2. India Sunitinib malate market
7.4.3. Japan Sunitinib malate market
7.4.4. Australia Sunitinib malate market
7.4.5. South Korea Sunitinib malate market
7.4.6. Rest of Asia Pacific Sunitinib malate market
7.5. Latin America Sunitinib malate market Snapshot
7.5.1. Brazil Sunitinib malate market
7.5.2. Mexico Sunitinib malate market
7.6. Rest of The World Sunitinib malate market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Pfizer Incorporation
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Topcarepharm
8.2.3. Njfirstpharm
8.2.4. J&K Scientific
8.2.5. Targetmol
8.2.6. Synthland Ltd
8.2.7. Teva Pharmaceutical Industries Ltd.
8.2.8. Astellas Pharma, Inc.
8.2.9. Dendreon Corporation
8.2.10. Ferring Pharmaceuticals, Inc.
Chapter 9. Research Application
9.1. Research Application
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Sunitinib malate market , report scope
TABLE 2. Global Sunitinib malate market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Sunitinib malate market estimates & forecasts by Type 2018-2027 (USD Billion)
TABLE 4. Global Sunitinib malate market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 5. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of global Sunitinib malate market .
TABLE 76. List of primary sources used in the study of global Sunitinib malate market .
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.

List of figures
FIG 1. Global Sunitinib malate market , research methodology
FIG 2. Global Sunitinib malate market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Sunitinib malate market , key trends 2019
FIG 5. Global Sunitinib malate market , growth prospects 2020-2027
FIG 6. Global Sunitinib malate market , porters 5 force model
FIG 7. Global Sunitinib malate market , pest analysis
FIG 8. Global Sunitinib malate market , value chain analysis
FIG 9. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Sunitinib malate market , regional snapshot 2018 & 2027
FIG 18. North America Sunitinib malate market 2018 & 2027 (USD Billion)
FIG 19. Europe Sunitinib malate market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Sunitinib malate market 2018 & 2027 (USD Billion)
FIG 21. Latin America Sunitinib malate market 2018 & 2027 (USD Billion)
FIG 22. Global Sunitinib malate market , company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のスニチニブリンゴ酸塩市場2021年ー2027年:種類別(純度99%以上、純度98%以上、純度97%以上)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆